iracon19

35th ANNUAL CONFERENCE OF THE INDIAN RHEUMATOLOGY ASSOCIATION PUDUCHERRY | 5-8 DECEMBER


IRACON 2019 Abstract submission Guidelines

A. Abstract preparation guidelines

1.Abstracts on original (Clinical/Basic) research

MS Word file, Structured, no more than 300 words (excluding title, authors list and affiliation)

The Abstract should be structured into the following sections;

• Title

• Authors (List of authors, presenting author listed first)

• Affiliation (Institutional Affiliation)

• Email and phone number of submitting author

• Type of Study: (Clinical/ Basic)

• Subject: (Rheumatoid arthritis/ Spondyloarthritis/ Connective tissue disorder/ Vasculitis/ Paediatric rheumatology/ miscellaneous)

• Background

• Objectives

• Methods

• Results

• Conclusions

• References (optional)

Table: One table. Use the tabs function of MS word, do not use grid tables. Give a title to the label. Embed the table in the main text document

Images: One image in high quality JPEG or PNG format. Send a clearly labelled figure (e.g. Figure 1. MRI wrist) as a separate file.

2. Abstracts on Case reports/ case series

MS Word file, structured, no more than 300 words (excluding title, authors list, affiliation, type of study, subject, email id and phone number)

The Abstract should be structured into the following sections;

• Title

• Authors (List of authors, presenting author listed first)

• Affiliation (Institutional Affiliation)

• Email and phone number of submitting author

• Case report/ case series

• Discussion

• Conclusion

• Conclusions

• References (optional)

Table: One table. Use the tab function of MS word, do not use grid tables. Give a title to the label. Embed the table in the main text document

Images: Two images in high quality JPEG or PNG format. Send a clearly labeled (e.g. Figure 1. MRI of wrist) as a separate file.

B. Abstract Rules

• Members and non-members of the Indian Rheumatology Association are eligible to submit an abstract.

• Abstracts that describe original basic and clinical science related to the broad area of rheumatic diseases may be submitted.

• If the abstract reports results of a clinical trial, you will be required to provide information on the trial phase and the trial registration with Clinical Trial Registry of India (CTRI).

• The abstract should not have been already published or should not be a part of a publication in a peer reviewed journal.

• Any work with human or animal subjects reported in submitted abstracts must comply with the guiding principles for experimental procedures in the World Medical Association Declaration of Helsinki.

• Last date for submission of abstracts is: 31st August, 2019.

• Registration for the conference is mandatory for presentation of the abstract.

• Abstracts will be judged according to the scientific merit and relevance by the scientific committee.

• The title or body of the abstract should not include names of individuals or the names of the institutions.

• Abstract should not contain brand names, trade names or non-standard acronyms or any commercial advertisements.

• The presenting author should be willing to present the work during the IRACON 2019 as either an oral platform presentation or poster presentation as assigned by the scientific committee.

• It is implied that the authors, by virtue of submission of the abstract, agree to the publication of the same in the souvenir of the conference/Indian journal of Rheumatology.

• Abstracts can only be submitted online via the online abstract submission system on www.iracon2019.com

• Abstracts sent by post or email will not be accepted. No exceptions will be made.

• Please ensure that your abstract does not contain spelling, grammatical or scientific errors, as it will be reproduced exactly as submitted. No proofreading will be done.

• Abstract acceptance will be in one of two categories: oral presentation or poster presentation.

• The final decision about acceptance of an abstract will be taken by the IRACON Scientific Committee. IRACON does not correspond on the reasons for acceptance/rejection of an abstract.

• Should you decide to withdraw your abstract, a written statement reflecting the reasons for this decision must be sent to the IRACON Secretariat not later than 15th Aug 2019.

• If an abstract is accepted as a poster presentation, the presenting author will be requested to be available for discussion during the corresponding poster viewing session.

• If an abstract is selected for oral presentation, the presenting author, as specified at submission, will be requested to present it in the assigned session. At the time of abstract submission, the submitter must identify who will be the presenting author.

• To be eligible as presenting author, the individual will be required to give an undertaking that he/she had full access to all data in the study and takesfull responsibility for the integrity of the data, accuracy of data analysis, and has the approval of other authors for presentation. The presenting author need not be the first author, but must be a listed author on the abstract. Only one presenter is permitted per abstract.

Please Note :

• The presenting author is the sole point of contact for all abstract co-authors. The organizing committee will direct all co-author inquiries to the presenting author.

• The organizing committee requests the author(s) to refrain from contacting the organisers or scientific chair personally or telephonically. Any queries regarding abstract status, notification, distribution, and/or publication dates etc. may be sent to the IRACON through email.

• The decision of the scientific committee to accept/reject the abstract and the mode of presentation (oral/poster) would be final. No correspondence/recommendation shall be entertained in this regard.